0002062676-25-000001.txt : 20250320 0002062676-25-000001.hdr.sgml : 20250320 20250320150504 ACCESSION NUMBER: 0002062676-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250320 DATE AS OF CHANGE: 20250320 EFFECTIVENESS DATE: 20250320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOPHY, INC. CENTRAL INDEX KEY: 0002062676 ORGANIZATION NAME: IRS NUMBER: 843857794 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-541598 FILM NUMBER: 25756015 BUSINESS ADDRESS: STREET 1: 1650 MARKET ST., SUITE 4810 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 267.800.8697 MAIL ADDRESS: STREET 1: 1650 MARKET ST., SUITE 4810 CITY: PHILADELPHIA STATE: PA ZIP: 19103 D 1 primary_doc.xml X0708 D LIVE 0002062676 BIOPHY, INC. 1650 MARKET ST., SUITE 4810 PHILADELPHIA PA PENNSYLVANIA 19103 267.800.8697 DELAWARE Trial Risk Index, Inc. None Corporation true DAVID LATSHAW II 1650 MARKET ST., SUITE 4810 PHILADELPHIA PA PENNSYLVANIA 19103 Executive Officer Director CHIEF EXECUTIVE OFFICER PHILIP BROWNE 1650 MARKET ST., SUITE 4810 PHILADELPHIA PA PENNSYLVANIA 19103 Director DANIEL SCIUBBA 1650 MARKET ST., SUITE 4810 PHILADELPHIA PA PENNSYLVANIA 19103 Director CAITLIN JAYE-YAN 1650 MARKET ST., SUITE 4810 PHILADELPHIA PA PENNSYLVANIA 19103 Executive Officer SECRETARY Other Technology Decline to Disclose 06b false 2025-03-04 false true false 0 6607500 6607500 0 $6,407,500.00 of each of the Total Offering Amount and Total Amount Sold includes principal on instruments convertible or exercisable into equity of the Issuer. false 56 0 0 0 All proceeds will be used for working capital. false BIOPHY, INC. DAVID LATSHAW II DAVID LATSHAW II CHIEF EXECUTIVE OFFICER 2025-03-20